SELECTED PUBLICATIONS:

Alnaji FG, Holmes JR, Rendon G, Vera JC, Fields CJ, Martin, BE, and Brooke CB. 2018

Illumina-based sequencing framework for accurate detection and mapping of influenza virus defective interfering particle-associated RNAs

BioRxiv. doi:10.1101/440651

Diefenbacher M, Sun J, and Brooke CB. 2018

The parts are greater than the whole: the role of semi-infectious particles in influenza A virus biology

Current Opinion in Virology. doi:10.1016/j.coviro.2018.07.002

 

Koelle K, Farrell A, Brooke CB, and Ke R. 2018

Within-host infectious disease models accommodating cellular coinfection, with an application to influenza

BioRxiv. doi:10.1101/359067

 

Sun J and Brooke CB. 2018

Influenza A virus superinfection potential is regulated by viral genomic heterogeneity

BioRxiv. doi:10.1101/286070

 

Kosik I*, Ince WL*, Gentles LE*, Oler AJ, Kosikova M, Angel M, Magadan JG, Xie H, Brooke CB^, and Yewdell JW. 2018^.

Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs

PLOS Pathogens. doi:10.1371/journal.ppat.1006796. *,^ Authors contributed equally

 

Brooke CB. 2017.

Population Diversity and Collective Interactions during Influenza Virus Infection

J. Virol. doi:10.1128/JVI.01164-17

 

Brooke CB*, Ince WL*, Wei J, Bennink JR, and Yewdell JW. 2014. 

Influenza A virus nucleoprotein selectively decreases neuraminidase gene segment packaging while enhancing fitness and transmissibility.

PNAS. 111(47): 16854-16859. *Authors contributed equally

 

Brooke CB. 2014. 

Biological activities of ‘noninfectious’ influenza A particles.

Future Virol. 9(1):41-51. 

 

Brooke CB, Ince WL, Wrammert J, Ahmed R, Wilson PC, Bennink JR, and Yewdell JW. 2012. 

Most influenza A virions fail to express at least one essential viral protein.

J. Virol. 87(6): 3155-62.

 

FULL LIST